help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yamamoto, Y.
Right arrow Articles by Saruta, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yamamoto, Y.
Right arrow Articles by Saruta, T.
The Journal of Clinical Endocrinology & Metabolism Vol. 89, No. 1 87-90
Copyright © 2004 by The Endocrine Society

Adiponectin, an Adipocyte-Derived Protein, Predicts Future Insulin Resistance: Two-Year Follow-Up Study in Japanese Population

Yukihiro Yamamoto, Hiroshi Hirose, Ikuo Saito, Kanako Nishikai and Takao Saruta

Department of Internal Medicine (Y.Y., H.H., I.S., K.N., T.S.) and Health Center (H.H., I.S.), Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan

Address all correspondence and requests for reprints to: Yukihiro Yamamoto, M.D., Department of Internal Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan. E-mail: yukihiro{at}hh.iij4u.or.jp.

It has been reported that the serum adiponectin level was negatively correlated with body mass index (BMI), insulin resistance index, and triglycerides and was positively correlated with high-density lipoprotein cholesterol in several cross-sectional studies. However, the causal relationship has not been elucidated. We investigated whether the baseline adiponectin level could predict subsequent changes in insulin resistance, lipid profile, or body weight in a 2-yr longitudinal study. This study included 590 male Japanese subjects, aged 30–65 yr, who received annual health checkups in both 2000 and 2002. Blood pressure, heart rate, and anthropometric and metabolic parameters, including serum insulin and adiponectin levels, were determined. The insulin resistance index was calculated based on homeostasis model assessment. Baseline adiponectin level was not correlated with the subsequent change in lipid profile or BMI in 2 yr after adjustment for each baseline value. However, the baseline adiponectin level was negatively correlated with subsequent changes in insulin and insulin resistance index based on homeostasis model assessment, even after adjustment for change in BMI (r = -0.162 and r = -0.140, respectively). These findings suggest that the serum adiponectin concentration predicts subsequent changes in insulin resistance, but not in lipid profile or body weight.

This work was supported in part by research grants (to Y.Y. and H.H.) from Keio University (Tokyo, Japan).

Abbreviations: AICAR, 5-Aminoimidazole-4-carboxamide ribonucleoside; AMPK, 5'-AMP-activated protein kinase; BMI, body mass index; HDL, high-density lipoprotein; HOMA-IR, insulin resistance index based on homeostasis model assessment; LDL, low-density lipoprotein.




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
M.-F. Hivert, L. M. Sullivan, C. S. Fox, D. M. Nathan, R. B. D'Agostino Sr., P. W. F. Wilson, and J. B. Meigs
Associations of Adiponectin, Resistin, and Tumor Necrosis Factor-{alpha} with Insulin Resistance
J. Clin. Endocrinol. Metab., August 1, 2008; 93(8): 3165 - 3172.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
K. J. Mather, T. Funahashi, Y. Matsuzawa, S. Edelstein, G. A. Bray, S. E. Kahn, J. Crandall, S. Marcovina, B. Goldstein, R. Goldberg, et al.
Adiponectin, Change in Adiponectin, and Progression to Diabetes in the Diabetes Prevention Program
Diabetes, April 1, 2008; 57(4): 980 - 986.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
N. Zhang, Y.-H. Shi, C.-F. Hao, H. F Gu, Y. Li, Y.-R. Zhao, L.-C. Wang, and Z.-J. Chen
Association of +45G15G(T/G) and +276(G/T) polymorphisms in the ADIPOQ gene with polycystic ovary syndrome among Han Chinese women
Eur. J. Endocrinol., February 1, 2008; 158(2): 255 - 260.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
A Klamer, K Skogstrand, D M Hougaard, B Norgaard-Petersen, A Juul, and G Greisen
Adiponectin levels measured in dried blood spot samples from neonates born small and appropriate for gestational age
Eur. J. Endocrinol., August 1, 2007; 157(2): 189 - 194.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. J. G. Hanley, D. Bowden, L. E. Wagenknecht, A. Balasubramanyam, C. Langfeld, M. F. Saad, J. I. Rotter, X. Guo, Y.-D. I. Chen, M. Bryer-Ash, et al.
Associations of Adiponectin with Body Fat Distribution and Insulin Sensitivity in Nondiabetic Hispanics and African-Americans
J. Clin. Endocrinol. Metab., July 1, 2007; 92(7): 2665 - 2671.
[Abstract] [Full Text] [PDF]


Home page
Arch. Dis. Child. Fetal Neonatal Ed.Home page
T. Siahanidou, H. Mandyla, G.-P. Papassotiriou, I. Papassotiriou, and G. Chrousos
Circulating levels of adiponectin in preterm infants
Arch. Dis. Child. Fetal Neonatal Ed., July 1, 2007; 92(4): F286 - F290.
[Abstract] [Full Text] [PDF]


Home page
J PsychopharmacolHome page
G.D. Cooper, L.C. Pickavance, J.P.H. Wilding, J.A. HarroLd, J.C.G. HaLford, and A.J. Goudie
Effects of olanzapine in male rats: enhanced adiposity in the absence of hyperphagia, weight gain or metabolic abnormalities
J Psychopharmacol, June 1, 2007; 21(4): 405 - 413.
[Abstract] [PDF]


Home page
NeurologyHome page
O. Y. Bang, J. L. Saver, B. Ovbiagele, Y. J. Choi, S. R. Yoon, and K. H. Lee
Adiponectin levels in patients with intracranial atherosclerosis
Neurology, May 29, 2007; 68(22): 1931 - 1937.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
T. A. Hopkins, N. Ouchi, R. Shibata, and K. Walsh
Adiponectin actions in the cardiovascular system
Cardiovasc Res, April 1, 2007; 74(1): 11 - 18.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
M. B. Snijder, R. J. Heine, J. C. Seidell, L. M. Bouter, C. D.A. Stehouwer, G. Nijpels, T. Funahashi, Y. Matsuzawa, I. Shimomura, and J. M. Dekker
Associations of adiponectin levels with incident impaired glucose metabolism and type 2 diabetes in older men and women: the hoorn study.
Diabetes Care, November 1, 2006; 29(11): 2498 - 2503.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
J. G. Woo, L. M. Dolan, R. Deka, R. D. Kaushal, Y. Shen, P. Pal, S. R. Daniels, and L. J. Martin
Interactions Between Noncontiguous Haplotypes in the Adiponectin Gene ACDC Are Associated With Plasma Adiponectin
Diabetes, February 1, 2006; 55(2): 523 - 529.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
N. C. Bush, B. E. Darnell, R. A. Oster, M. I. Goran, and B. A. Gower
Adiponectin Is Lower Among African Americans and Is Independently Related to Insulin Sensitivity in Children and Adolescents
Diabetes, September 1, 2005; 54(9): 2772 - 2778.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
J. B Ruige, D. P Ballaux, T. Funahashi, I. L Mertens, Y. Matsuzawa, and L. F Van Gaal
Resting metabolic rate is an important predictor of serum adiponectin concentrations: potential implications for obesity-related disorders
Am. J. Clinical Nutrition, July 1, 2005; 82(1): 21 - 25.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2004 by The Endocrine Society